SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-23-004948
Filing Date
2023-03-29
Accepted
2023-03-29 17:22:37
Documents
68
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K fencf-20221231x10k.htm   iXBRL 10-K 2575456
2 EX-23.1 fencf-20221231xex23d1.htm EX-23.1 5071
3 EX-31.1 fencf-20221231xex31d1.htm EX-31.1 15067
4 EX-31.2 fencf-20221231xex31d2.htm EX-31.2 15141
5 EX-32.1 fencf-20221231xex32d1.htm EX-32.1 8507
6 EX-99.1 fencf-20221231xex99d1.htm EX-99.1 260238
7 GRAPHIC fencf-20221231xex99d1001.jpg GRAPHIC 2446
  Complete submission text file 0001558370-23-004948.txt   8740066

Data Files

Seq Description Document Type Size
8 EX-101.SCH fencf-20221231.xsd EX-101.SCH 60284
9 EX-101.CAL fencf-20221231_cal.xml EX-101.CAL 41844
10 EX-101.DEF fencf-20221231_def.xml EX-101.DEF 234655
11 EX-101.LAB fencf-20221231_lab.xml EX-101.LAB 374814
12 EX-101.PRE fencf-20221231_pre.xml EX-101.PRE 361871
62 EXTRACTED XBRL INSTANCE DOCUMENT fencf-20221231x10k_htm.xml XML 1372886
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32295 | Film No.: 23776230
SIC: 2836 Biological Products, (No Diagnostic Substances)